 - Patients on full-dose anticoagulants must be on a stable dose of warfarin and have an in-range INR usually between 2 and 3 or be on a stable dose of LMW heparin; patients receiving anti-platelet agents are also eligible; in addition, patients who are on daily prophylactic aspirin or anticoagulation for atrial fibrillation are eligible 